Jecho Laboratories, Inc. Announces FDA Acceptance of Investigational New Drug (IND) Application for JLM019 for Advanced Malignancies
April 27, 2026 Frederick, MD – Jecho Laboratories, Inc. (“Jecho”), a clinical-stage biotechnology company focused on developing innovative therapeutics, announces that the U.S. Food and Drug Administration (FDA) has accepted…